Wang Hong, Tian Junping, Du Fenghe, Wang Tao
Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Iran J Kidney Dis. 2019 Jan;13(1):56-66.
This study aimed to investigate the influence of peritoneal transport characteristics on clinical outcome in nondiabetic and diabetic nephropathy peritoneal dialysis (PD) patients.
All 112 patients were from the PD Center. Peritoneal transport characteristic was assessed by peritoneal equilibration test. The patients were divided into 2 groups of high-transport group (HT) and non-high-transport group (non-HT) and followed-up till December 31st, 2010. The primary outcomes were all-cause death and technique failure.
The patients were followed-up for 65.9 ± 23.9 months. Diabetic nephropathy patients with HT had a higher all-cause mortality (P = .04) and technique failure (P = .04) than those with non-HT. There were no differences in outcomes between HT and non-HT subgroups without diabetic nephropathy. Cox regression demonrtrated that high peritoneal transport (HR, 2.369; 95% CI, 1.056 to 5.311), diabetic nephropathy (HR, 2.499; 95% CI, 1.134 to 5.508), age (HR, 1.081; 95% CI, 1.032 to 1.133), and peritoneal creatinine clearance (HR, 0.962; 95% CI, 0.929 to 0.997) independently predicted all-cause mortality in continuous ambulatory PD patients. Moreover, high peritoneal transport (HR, 2.299; 95% CI, 1.079 to 4.899) and age (HR, 1.070; 95% CI, 1.026 to 1.116) predicted technique failure in continuous ambulatory PD patients.
Diabetic nephropathy PD patients with HT had a higher all-cause mortality and technique failure than those with non-HT, but we did not find the correlation between peritoneal transport and outcome in nondiabetic patients. The peritoneal transport was an independent predictor for outcomes in continuous ambulatory PD patients.
本研究旨在调查腹膜转运特性对非糖尿病和糖尿病肾病腹膜透析(PD)患者临床结局的影响。
112例患者均来自腹膜透析中心。通过腹膜平衡试验评估腹膜转运特性。将患者分为高转运组(HT)和非高转运组(非HT),随访至2010年12月31日。主要结局为全因死亡和技术失败。
患者随访时间为65.9±23.9个月。糖尿病肾病HT组患者的全因死亡率(P = 0.04)和技术失败率(P = 0.04)高于非HT组。非糖尿病肾病的HT组和非HT组亚组之间的结局无差异。Cox回归显示,高腹膜转运(HR,2.369;95%CI,1.056至5.311)、糖尿病肾病(HR,2.499;95%CI,1.134至5.508)、年龄(HR,1.081;95%CI,1.032至1.133)和腹膜肌酐清除率(HR,0.962;95%CI,0.929至0.997)独立预测持续非卧床腹膜透析患者的全因死亡率。此外,高腹膜转运(HR,2.299;95%CI,1.079至4.899)和年龄(HR,1.070;95%CI,1.026至1.116)预测持续非卧床腹膜透析患者的技术失败。
糖尿病肾病腹膜透析HT组患者的全因死亡率和技术失败率高于非HT组,但我们未发现非糖尿病患者腹膜转运与结局之间的相关性。腹膜转运是持续非卧床腹膜透析患者结局的独立预测因素。